Literature DB >> 20551222

Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway.

Ingrid Nermoen1, Eystein S Husebye, Johan Svartberg, Kristian Løvås.   

Abstract

BACKGROUND: Patients with classical congenital adrenal hyperplasia (CAH) require life-long corticosteroid therapy, with uncertain health outcome. Investigations of subjective health status in unselected populations of adult patients are needed.
OBJECTIVE: To identify all adult Norwegian patients with CAH and obtain population-based data on subjective and psychological health status, working ability and fertility. PATIENTS, METHODS AND
DESIGN: Classical CAH patients were identified through search in electronic diagnosis registries at all the university hospitals in Norway. The diagnosis was verified by scrutiny of medical records. The patients were invited to a questionnaire survey including medical history, and the Short Form-36 (SF-36) and Quality of Life Scale questionnaires. The questionnaire responses and fertility data were compared with normative data.
RESULTS: We identified 104 adult patients (101 alive) with classical CAH (63% female), yielding overall incidence at 1/20,000 live births (1/16,000 in females). Seventy-two (72%) responded; median age 38 years (range 18-72). All the SF-36 scales were significantly impaired, most pronounced for general health and vitality perception. Working disability was reported by 19% of the patients, compared with 10% in the general population. The female patients were often single, and the CAH women had only 21% of the expected number of children compared with the general population.
CONCLUSION: In this population-based survey of patients with classical CAH, we found that subjective health status and working ability were impaired, and that fertility was reduced in females. There is a need for improvement of the medical treatment and the general care of this patient group.

Entities:  

Mesh:

Year:  2010        PMID: 20551222     DOI: 10.1530/EJE-10-0284

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  29 in total

1.  Utilization of health care services and satisfaction with care in adults affected by disorders of sex development (DSD).

Authors:  Ute Thyen; Anke Lux; Martina Jürgensen; Olaf Hiort; Birgit Köhler
Journal:  J Gen Intern Med       Date:  2014-08       Impact factor: 5.128

2.  Quality of life, social situation, and sexual satisfaction, in adult males with congenital adrenal hyperplasia.

Authors:  Henrik Falhammar; Helena Filipsson Nyström; Marja Thorén
Journal:  Endocrine       Date:  2014-01-10       Impact factor: 3.633

3.  Severe fatigue in patients with adrenal insufficiency: physical, psychosocial and endocrine determinants.

Authors:  V Giebels; H Repping-Wuts; G Bleijenberg; J M Kroese; N Stikkelbroeck; A Hermus
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

Review 4.  Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review.

Authors:  Matthias Büttner; Thomas J Musholt; Susanne Singer
Journal:  Endocrine       Date:  2017-08-18       Impact factor: 3.633

Review 5.  Clinical outcomes in the management of congenital adrenal hyperplasia.

Authors:  Henrik Falhammar; Marja Thorén
Journal:  Endocrine       Date:  2012-01-07       Impact factor: 3.633

Review 6.  Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.

Authors:  Henrik Falhammar; Anna Nordenström
Journal:  Endocrine       Date:  2015-06-17       Impact factor: 3.633

7.  Multidimensional Aspects of Female Sexual Function in Congenital Adrenal Hyperplasia: A Case-Control Study.

Authors:  Maggie Dwiggins; Brittany Brookner; Kylie Fowler; Padmasree Veeraraghavan; Veronica Gomez-Lobo; Deborah P Merke
Journal:  J Endocr Soc       Date:  2020-09-04

8.  Health-related quality of life in children with disorders of sex development (DSD).

Authors:  Martina Jürgensen; Anke Lux; Sebastian Benedikt Wien; Eva Kleinemeier; Olaf Hiort; Ute Thyen
Journal:  Eur J Pediatr       Date:  2014-01-28       Impact factor: 3.183

9.  Long-term use of continuous subcutaneous hydrocortisone infusion therapy in patients with congenital adrenal hyperplasia.

Authors:  Ashwini Mallappa; Aikaterini A Nella; Ninet Sinaii; Hamsini Rao; Verena Gounden; Ashley F Perritt; Parag Kumar; Alexander Ling; Chia-Ying Liu; Steven J Soldin; Deborah P Merke
Journal:  Clin Endocrinol (Oxf)       Date:  2018-08-08       Impact factor: 3.478

Review 10.  Treatment and health outcomes in adults with congenital adrenal hyperplasia.

Authors:  Thang S Han; Brian R Walker; Wiebke Arlt; Richard J Ross
Journal:  Nat Rev Endocrinol       Date:  2013-12-17       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.